Einhaus, Jakob
Rochwarger, Alexander
Mattern, Sven
Gaudillière, Brice
Schürch, Christian M. http://orcid.org/0000-0002-1792-1768
Funding for this research was provided by:
German Research Foundation (EI 1249/1-1)
Universitätsklinikum Tübingen
Article History
Received: 2 January 2023
Revised: 22 January 2023
Accepted: 31 January 2023
First Online: 9 February 2023
Declarations
:
: C.M.S. is a scientific advisor to AstraZeneca plc, and is on the scientific advisory board of, has stock options in, and has received research funding from Enable Medicine, Inc.